Both in Biotechnology
Atara Biotherapeutics vs Tevogen
Over the past year ATRA returned −39.4% and TVGN returned −80.6%; their daily moves had a correlation of -0.02.
ATRA −39.4% TVGN −80.6%Growth of $1, one year, split-adjusted
| Metric | ATRA | TVGN |
|---|---|---|
| Price | $8.40 | $5.69 |
| Market cap | $84.3M | $89.5M |
| Today | +2.44% | −3.89% |
| 1 month | −13.8% | −12.3% |
| 6 months | +63.1% | −19.5% |
| Year to date | −53.6% | −65.6% |
| 1 year | −39.4% | — |
| Revenue growth (YoY) | −96.4% | — |
| Gross margin | 69.7% | — |
| Net margin | −767.3% | — |
| P/E (TTM) | — | — |
| Price / sales | 13.6× | — |
| Net cash | $9.9M | -$7.0M |
| Dividend yield | — | — |
| Volatility (60d) | 65.2% | 61.0% |
| Short % of float | 11.2% | 3.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).